These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34697930)

  • 21. Schools: a gaping hole in England's covid strategy.
    Pagel C
    BMJ; 2021 Sep; 374():n2115. PubMed ID: 34470743
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19 and Public Health: Looking Back, Moving Forward.
    Juliano C; Castrucci B; Fraser MR
    J Public Health Manag Pract; 2021; 27 Suppl 1, COVID-19 and Public Health: Looking Back, Moving Forward():S1-S4. PubMed ID: 33239556
    [No Abstract]   [Full Text] [Related]  

  • 23. [The COVID-19 pandemic].
    Bessis S
    Med Mal Infect; 2020 Sep; 50(8S):8S20-8S24. PubMed ID: 33357972
    [No Abstract]   [Full Text] [Related]  

  • 24. Stepwise Strategy of Social Distancing in Korea.
    Park IN; Yum HK
    J Korean Med Sci; 2020 Jul; 35(28):e264. PubMed ID: 32686376
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA authorizes first single-shot COVID-19 vaccine.
    Mullard A
    Nat Rev Drug Discov; 2021 Apr; 20(4):251. PubMed ID: 33707753
    [No Abstract]   [Full Text] [Related]  

  • 26. New Zealand's science-led response to the SARS-CoV-2 pandemic.
    Geoghegan JL; Moreland NJ; Le Gros G; Ussher JE
    Nat Immunol; 2021 Mar; 22(3):262-263. PubMed ID: 33627881
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 may become nanomedicine's finest hour yet.
    Friedrichs S; Bowman DM
    Nat Nanotechnol; 2021 Apr; 16(4):362-364. PubMed ID: 33854220
    [No Abstract]   [Full Text] [Related]  

  • 28. Being fair to participants in placebo-controlled COVID-19 vaccine trials.
    Dal-Ré R; Orenstein W; Caplan AL
    Nat Med; 2021 Jun; 27(6):938. PubMed ID: 33903751
    [No Abstract]   [Full Text] [Related]  

  • 29. Reflections on SARS-CoV-2 new strain contagiousness and its prevention with mRNA vaccines.
    García-Vigil JL; García-Alvarez JL
    Gac Med Mex; 2021; 157(3):318. PubMed ID: 34667321
    [No Abstract]   [Full Text] [Related]  

  • 30. Balancing Act: Public Health and Autonomy in COVID-19 Vaccination Decisions.
    Young J
    Prof Case Manag; 2021 Nov-Dec 01; 26(6):313-315. PubMed ID: 34609347
    [No Abstract]   [Full Text] [Related]  

  • 31. The race for a COVID-19 vaccine.
    Lavigne SE
    Can J Dent Hyg; 2020 Oct; 54(3):107-109. PubMed ID: 33240370
    [No Abstract]   [Full Text] [Related]  

  • 32. Response of Clinical Laboratories to the Ongoing COVID-19 Pandemic.
    Kim YJ; Sung H; Ki CS; Hur M
    Ann Lab Med; 2021 Nov; 41(6):519-520. PubMed ID: 34108278
    [No Abstract]   [Full Text] [Related]  

  • 33. Audio Interview: An International Look at Covid-19.
    Rubin EJ; Baden LR; Nottage K; O'Connell J; Wong G; Morrissey S
    N Engl J Med; 2021 Jan; 384(3):e19. PubMed ID: 33471986
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between the Relaxation of Public Health and Social Measures and Transmission of the SARS-CoV-2 Omicron Variant in South Korea.
    Ryu S; Han C; Kim D; Tsang TK; Cowling BJ; Lee S
    JAMA Netw Open; 2022 Aug; 5(8):e2225665. PubMed ID: 35960524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The COVID-19 exit strategy-why we need to aim low.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2021 Mar; 21(3):297. PubMed ID: 33581748
    [No Abstract]   [Full Text] [Related]  

  • 37. Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam.
    Rubin EJ; Baden LR; Northam RS; Morrissey S
    N Engl J Med; 2021 Feb; 384(5):e25. PubMed ID: 33534981
    [No Abstract]   [Full Text] [Related]  

  • 38. Professional academic organizations on infectious disease Joint Statement on COVID-19.
    Epidemiol Health; 2020; 42():e2020017. PubMed ID: 32344997
    [No Abstract]   [Full Text] [Related]  

  • 39. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 evolution during the pandemic - Implications of new SARS-CoV-2 variants on disease control and public health policies.
    van Oosterhout C; Hall N; Ly H; Tyler KM
    Virulence; 2021 Dec; 12(1):507-508. PubMed ID: 33494661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.